脑通口服液治疗动脉硬化性脑梗塞的临床观察  

Clinical Study of Treatment with Naotong Oral Solution on Arteriosclerosis Cerebral Embolism

作　　者：田立[1] 唐可清[1] 王立琴[1] 李钦孝 唐可欣[2] 

机构地区：[1]潍坊市中医院,山东潍坊261041 [2]潍坊医学院

出　　处：《潍坊医学院学报》2000年第4期266-268,共3页Acta Academiae Medicinae Weifang

基　　金：山东省中医药管理局课题(课题号:1996年0106号)

摘　　要：目的　探讨脑通口服液治疗动脉硬化性脑梗塞的疗效及机制。方法　将 135例急性期脑梗塞患者随机分为脑通口服液组 (治疗组 97例 ) ,及脑血康口服液组 (对照组 38例 ) ,观察比较其疗效。结果　治疗组 97例总有效率 97.9% ,明显优于对照组的 89.5% ,P<0 .0 5。并有较好的降血脂、改善脑血流作用。脑通口服液可明显减轻大鼠急性脑梗塞模型缺血区脑组织损伤 ,使筛状软化灶缩小、局限化 ,使新生血管增生 ,巨噬细胞浸润 ,胶质细胞和纤维母细胞增生 ,并能使动物神经病学评分明显降低 ,改善动物感觉、运动功能。结论　该药能扩张脑血管 ,改善脑循环 ,有较高的临床推广价值。Objective To observe the effect and mechnism of Naotong oral solution (NTOS) on arteriosclerosis cerebral embolism.Method 135 cerebral embolism cases were randomly divided into two groups.The experimental group (97 cases,treated with NTOS) and the control group (38 cases,treated with Naoxuekang oral soluation NXK).Result The effective rates in experimental group and contnol group were 97.9% and 89.5% respectively.The difference between the rate of the two groups was significant (P<0.05).Conclusion NTOS has significant effect on arteriosclerosis cerebral embolism and it's effect is better than NXK. [

关 键 词：脑通口服液 动脉硬化性脑梗塞 治疗学 

分 类 号：R743.330.5[医药卫生—神经病学与精神病学]